CXBS (Corix Bioscience) EBIT per Share: $-0.43 (TTM As of Sep. 2017)


What is Corix Bioscience EBIT per Share?

Corix Bioscience CXBS -99.00% EBIT per Share is $-0.43 as of Sep. 2017.

Corix Bioscience's EBIT per Share for the three months ended in Sep. 2017 was $-0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2017 was $-0.43.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Corix Bioscience's EBIT per Share or its related term are showing as below:

CXBS's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.5
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Corix Bioscience's EBIT for the three months ended in Sep. 2017 was $-0.28 Mil.

Corix Bioscience  (OTCPK:CXBS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Corix Bioscience EBIT per Share Related Terms

Corix Bioscience EBIT per Share Historical Data

* Premium members only.

The historical data trend for Corix Bioscience's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Corix Bioscience EBIT per Share Chart

Corix Bioscience Annual Data
Trend Jan09 Jan10 Jan11 Jan12 Jan13 Jan14 Jan15 Dec16
EBIT per Share
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.75 -0.47

Corix Bioscience Quarterly Data
Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.33 -0.01 -0.08 -0.01

Corix Bioscience EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Corix Bioscience's EBIT per Share for the fiscal year that ended in Dec. 2016 is calculated as

EBIT per Share(A: Dec. 2016 )
=EBIT/Shares Outstanding (Diluted Average)
=-4.045/8.527
=-0.47

Corix Bioscience's EBIT per Share for the quarter that ended in Sep. 2017 is calculated as

EBIT per Share(Q: Sep. 2017 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.281/20.515
=-0.01

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.43 mean?
Corix Bioscience (CXBS) has a EBIT per Share of $-0.43 as of Sep. 2017. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Corix Bioscience and its competitors.
Is Corix Bioscience's EBIT per Share too high?
Corix Bioscience's current EBIT per Share is $-0.43.
How does Corix Bioscience's EBIT per Share compare to BKIT and YBAO?
Corix Bioscience's EBIT per Share of $-0.43 can be compared against companies in the Drug Manufacturers industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Corix Bioscience and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Corix Bioscience's current EBIT per Share is $-0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Corix Bioscience stock overvalued right now?
Corix Bioscience (CXBS) has a current EBIT per Share of $-0.43. The current EBIT per Share is $-0.43. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Corix Bioscience (CXBS), the current EBIT per Share is $-0.43 as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Corix Bioscience Business Description

Address 18662 MaCaurther Boulevard, Suite 200, Irvine, CA, USA, 85085
Corix Bioscience Inc is a United States-based research and development firm of cannabidiol (CBD) products and treatments. It is engaged in the business of producing organic CBD oil used for medical applications and treatments. In addition, the group is also focused on the production of tetrahydrocannabivarin oil. The company is focused on operations in Oregon, California, and Nevada, United States.